MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN AND PREGNANCY-ASSOCIATED PLASMA PROTEIN-A, MARKERS FOR FETAL DOWN-SYNDROME AT 8-14 WEEKS

被引:50
作者
MACINTOSH, MCM
ILES, R
TEISNER, B
SHARMA, K
CHARD, T
GRUDZINSKAS, JG
WARD, RHT
MULLER, F
机构
[1] STATE SERUM INST,DIV IMMUNOL,COPENHAGEN,DENMARK
[2] ST BARTHOLOMEWS HOSP,COLL MED,DEPT REPROD PHYSIOL,LONDON EC1A 7BE,ENGLAND
[3] UNIV LONDON LONDON HOSP,COLL MED,LONDON E1 1BB,ENGLAND
[4] UNIV COLL HOSP LONDON,DEPT OBSTET & GYNAECOL,LONDON EC1A 7BE,ENGLAND
[5] HOP AMBROISE PARE,BIOCHEM LAB,F-92104 BOULOGNE,FRANCE
关键词
HUMAN CHORIONIC GONADOTROPIN (HCG); PREGNANCY-ASSOCIATED PLASMA PROTEIN-A (PAPP-A); SCREENING; DOWN SYNDROME;
D O I
10.1002/pd.1970140311
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Maternal serum levels of human chorionic gonadotrophin and its subunits (intact, alpha, and free betahCG) and pregnancy-associated plasma protein A (PAPP-A) were measured in 279 women between 8 and 14 weeks' gestation. This group included 23 pregnancies in which the fetus had Down syndrome (DS), diagnosed either at birth or during the second trimester (n = 17) or from chorionic villus sampling (CVS) (n = 6). Normal medians were determined from the 258 apparently normal pregnancies. The median levels of intact hCG (1.4 MOM) and free betahCG (2.1 MOM) were significantly raised, whereas the median level of PAPP-A (0.39 MOM) was significantly lower in the DS pregnancies when compared with the control group. Levels of alphahCG were similar in both the control and the DS pregnancies. Analysis of samples taken prior to 14 weeks' gestation demonstrated that only PAPP-A (0.34 MOM) was significantly altered in DS pregnancies. However, after the exclusion of DS cases diagnosed at CVS, the median intact hCG (1.56 MOM), free betahCG (2-27 MOM), and alphahCG (1.8 MOM) were all raised in DS pregnancies. This emphasizes the problem of the interpretation of biochemical markers when DS cases are diagnosed at CVS.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 27 条
  • [21] FREE BETA-HUMAN CHORIOGONADOTROPIN IN DOWNS-SYNDROME SCREENING - A MULTICENTER STUDY OF ITS ROLE COMPARED WITH OTHER BIOCHEMICAL MARKERS
    SPENCER, K
    COOMBES, EJ
    MALLARD, AS
    WARD, AM
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1992, 29 : 506 - 518
  • [22] SPENCER K, 1991, CLIN CHEM, V37, P809
  • [23] FREE BETA-HCG AS 1ST-TRIMESTER MARKER FOR FETAL TRISOMY
    SPENCER, K
    MACRI, JN
    AITKEN, DA
    CONNOR, JM
    [J]. LANCET, 1992, 339 (8807) : 1480 - 1480
  • [24] EARLY DETECTION OF DOWNS-SYNDROME USING FREE BETA-HUMAN CHORIOGONADOTROPIN
    SPENCER, K
    MACRI, JN
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1992, 29 : 349 - 350
  • [25] 1ST-TRIMESTER MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN AS A MARKER FOR FETAL CHROMOSOMAL DISORDERS
    VANLITH, JMM
    [J]. PRENATAL DIAGNOSIS, 1992, 12 (06) : 495 - 504
  • [26] 1ST TRIMESTER CONCENTRATIONS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A AND PLACENTAL PROTEIN-14 IN DOWNS-SYNDROME
    WALD, N
    STONE, R
    CUCKLE, HS
    GRUDZINSKAS, JG
    BARKAI, G
    BRAMBATI, B
    TEISNER, B
    FUHRMANN, W
    [J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6844) : 28 - 28
  • [27] Wenger D, 1990, Am J Med Genet Suppl, V7, P89